Genetic ablation of smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia

49Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

The contribution of the microenvironment to pancreatic acinar-to-ductal metaplasia (ADM), a preneoplastic transition in oncogenic Kras-driven pancreatic cancer progression, is currently unclear. Herewe show that disruption of paracrine Hedgehog signaling via genetic ablation of Smoothened (Smo) in stromal fibroblasts in a KrasG12D mouse model increased ADM. Smo-deleted fibroblasts had higher expression of transforming growth factor-α (Tgfa) mRNA and secreted higher levels of TGFα, leading to activation of EGFR signaling in acinar cells and increased ADM. The mechanism involved activation of AKT and noncanonical activation of the GLI family transcription factor GLI2. GLI2 was phosphorylated at Ser230 in an AKT-dependent fashion and directly regulated Tgfa expression in fibroblasts lacking Smo. Additionally, Smo-deleted fibroblasts stimulated the growth of KrasG12D/Tp53R172H pancreatic tumor cells in vivo and in vitro. These results define a non-cell-autonomous mechanism modulating KrasG12DdrivenADMthat is balanced by cross-talk between Hedgehog/SMO and AKT/GLI2 pathways in stromal fibroblasts.

Cite

CITATION STYLE

APA

Liu, X., Pitarresi, J. R., Cuitiño, M. C., Kladney, R. D., Woelke, S. A., Sizemore, G. M., … Ostrowski, M. C. (2016). Genetic ablation of smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia. Genes and Development, 30(17), 1943–1955. https://doi.org/10.1101/gad.283499.116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free